Speakers
Anna Podolanczuk
Assistant Professor - Pulmonary & Critical Care Medicine
Weill Cornell - Cornell University
Day One
Wednesday 14th June 2023
8:30 am | Panel Discussion – What is PPF? Delving into Defining Progression to Illuminate Research & Therapeutic Development for Progressive Fibroses
Day Two
Thursday 15th June 2023
8:30 am | Identifying & Highlighting Differences Between IPF & PPF to Inform Future Clinical Trial Endpoints
Annalisa Murgo
Researcher
Chiesi
Day Two
Thursday 15th June 2023
12:00 pm | Exploring the Consistency of Readouts Across Preclinical Models to Evaluate the Use of Novel Fibrosis Models in Preclinical Therapeutic Development
Cara Williams
Vice President, Head of Preclinical Biology, Inflammation, & Immunology
Pfizer
Day One
Wednesday 14th June 2023
8:25 am | Chair’s Opening Remarks
Chelsea Magin
Assistant Professor
University of Colorado
Day Two
Thursday 15th June 2023
1:30 pm | Engineering 3D Lung Models for Drug Discovery and Validation
Daniela Schloesser
Scientist
Boehringer Ingelheim
Pre-Conference Day Track A AM
Tuesday 13th June 2023
9:00 am | Shining a Spotlight on the Lung Microenvironment to Delve into Cell Type Populations & the Extracellular Matrix
David (Yupeng) He
Project Lead Inflammation/Immunology
Abbvie
Pre-Conference Day Track A AM
Tuesday 13th June 2023
9:00 am | Shining a Spotlight on the Lung Microenvironment to Delve into Cell Type Populations & the Extracellular Matrix
David Lynch
Radiologist
National Jewish Health
Day One
Wednesday 14th June 2023
2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs
9:00 am | Using Artificial Intelligence (AI) Techniques to Create an Estimate of Interstitial Lung Disease Progression
Elizabeth Volkmann
Associate Professor - Clinical & Medicine
UCLA Health Sciences
Pre-Conference Day Track A AM
Tuesday 13th June 2023
1:00 pm | From ILD Risk Factors & Therapeutic Strategies to Clinical Endpoints: Hailing a New Era of Progressive Pulmonary Fibrosis Therapeutics
Francesco Del Galdo
Professor of Experimental Medicine
University Of Leeds
Day One
Wednesday 14th June 2023
10:00 am | Implementing a Precision Medicine Model to Stratify SSc-ILD Patients for 12 Months Risk of Progression
George Washko
Associate Professor - Medicine
Harvard Medical School
Day One
Wednesday 14th June 2023
4:30 pm | Honing an AI/Quantitative Method to Access the Accumulating Morphological & Clinical Imaging Knowledge for Clinical & Technical Practice
2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs
Harris Perlman
Professor & Chief of Rheumatology
Northwestern University
Day One
Wednesday 14th June 2023
2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs
1:30 pm | Uncovering the Role of Monocytes & Tissue Macrophages Across Fibrotic ILDs to Illuminate the Key Predictors of Progression
Karim El Kasmi
Senior Associate Director
Boehringer Ingelheim
Day One
Wednesday 14th June 2023
12:00 pm | Session Overview to Be Confirmed
8:30 am | Panel Discussion – What is PPF? Delving into Defining Progression to Illuminate Research & Therapeutic Development for Progressive Fibroses
Kevin Hart
Associate Research Fellow (Scientific Director) - Fibrosis Exploratory Biology & Drug Discovery
Pfizer
Day One
Wednesday 14th June 2023
11:30 am | Identifying Scar-Associated Macrophages as Therapeutic Targets & Potential Biomarkers in Progressive Fibrosis
Madelyn Miller
Postdoctoral Scientist
El Lilly & Co
Day Two
Thursday 15th June 2023
2:30 pm | Oligonucleotides as Potential Therapies for Pulmonary Fibrosis
Mark Wilson
Principal Scientist
Genentech
Day Two
Thursday 15th June 2023
2:00 pm | Reversing Translational Efforts to Identify New Pathways Contributing to ILD-Expanding the gp130-Dependent Cytokine Axis
Peter Fernandes
Chief Executive Officer
Bellerophon Therapeutics
Day Two
Thursday 15th June 2023
9:00 am | Adapting Clinical Trial Design & Endpoints for ILD Therapeutic Development: Harnessing Digital Health Technology (DHT) Endpoints
Resat Cinar
Co-Chief of Fibrotic Diseases
The National Institutes of Health
Day One
Wednesday 14th June 2023
8:30 am | Panel Discussion – What is PPF? Delving into Defining Progression to Illuminate Research & Therapeutic Development for Progressive Fibroses
Pre-Conference Day Track A AM
Tuesday 13th June 2023
9:00 am | Shining a Spotlight on the Lung Microenvironment to Delve into Cell Type Populations & the Extracellular Matrix
Satish Madala
Professor & Basic Science Director
University of Cincinnati
Day Two
Thursday 15th June 2023
11:30 am | Using a Combination of Preclinical Models: The Way Forward for Mechanisms - Based Clinical Translation
Sydney Montessi
Assistant Professor of Medicine
Massachusetts General Hospital
Day One
Wednesday 14th June 2023
4:00 pm | Employing PET Probes in Early Phase Clinical Trials: From Target Engagement to Proof-Of-Concept
2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs
Vanessa Neiens
Biology Respiratory Lead
Pieris Pharmaceuticals
Day Two
Thursday 15th June 2023
10:00 am | Transitioning Inhaled Preclinical Studies to the Clinic: Development of PRS-220, an Inhaled Anticalin Protein targeting CTGF/CCN2 for the Treatment of Lung Fibrosis
Xia Gao
Biomarker Scientist
Genentech
Day One
Wednesday 14th June 2023
9:30 am | Illuminating Biomarker Discovery in Systemic Sclerosis Associated ILD to Understand the Similarities to IPF
Yannick Allanore
Professor of Rheumatology
University of Paris Cité
Day One
Wednesday 14th June 2023